Cargando…
PORTA VEIN THROMBOSIS (PVT) IN CIRRHOTIC PATIENTS PRE AND DURING THE PANDEMIC BY SARS-COV2
INTRODUCTION: Determining the incidence and prevalence of PVT is difficult due to the heterogeneity of risk factors. The prevalence in cirrhotics is 1% in compensated patients and 8-25% in decompensated patients. SARS-COV2 infection presents extrapulmonary manifestations such as coagulation disorder...
Autores principales: | Campoverde-Espinoza, C.A., Martínez-Tovar, A., Higuera de la Tijera, M.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804226/ http://dx.doi.org/10.1016/j.aohep.2021.100616 |
Ejemplares similares
-
Porta hepatis in relation to portal vein among Indians
por: Gaikwad, Mrinalini, et al.
Publicado: (2022) -
Management of Portal Vein Thrombosis in Cirrhotic Patients
por: Amitrano, Lucio, et al.
Publicado: (2009) -
Non-cirrhotic portal vein thrombosis – therapeutic challenge
por: Sarquis, Lucas Mansano, et al.
Publicado: (2022) -
Pregnancy in the Setting of Asymptomatic Non-Cirrhotic Chronic Portal Vein Thrombosis Complicated by Pre-Eclampsia
por: Üstüner, Işık, et al.
Publicado: (2013) -
Porta themis fiscal 2004 /
por: Calvo Nicolau, Enrique
Publicado: (2004)